Nov

09

2026

Hamlet BioPharma AB announces that the company presented its latest progress at the BioStock Life Science Summit on November 5, 2026. BioStock is an i...

Oct

28

2026

Hamlet BioPharma invites you to our monthly  meeting to be held on the 30th of October 2026, at 12:00. Please click on the link below to participate i...

Oct

08

2026

New insights into the mechanism of action of the anti-cancer drug Alpha1H are published today in Molecular Therapy, a Cell Press journal. The study ma...

Sep

24

2026

The Bio Report is a weekly podcast hosted by award-winning journalist, Daniel Levine. Produced by the Levine Media Group, the well-respected podcast f...

Sep

21

2026

New research findings defining BAMLET ‘s beneficial effects on metabolism have been published in Scientific Reports, a journal within the Nature Portf...

Sep

21

2026

Hamlet BioPharma invites you to our monthly investors’ meeting to be held on September 23rd 2026, at 12:00. Please click on the link below to particip...

Sep

17

2026

HAMLET BioPharma is proud to announce that the clinical phase of the Phase III trial has started. Patients with non-muscle invasive bladder cancer are...

Aug

28

2026

    ...

Aug

27

2026

Med anledning av publiceringen av bokslutskommunikén bjuder Hamlet BioPharma in till en livesänd digital pressträff fredagen den 28 augusti, 2026, klo...

Aug

05

2026

Hamlet BioPharma AB (publ) meddelar idag det preliminära utfallet av nyttjandet av teckningsoptioner av serie TO5B. Baserat på hittills registrerade t...

Jul

28

2026

Hamlet Biopharma, a company innovating the treatment of cancer and infections, today announced the grant and impending grant of new patents in the US ...

Jul

24

2026

Time Business News and  USA Wire both highlight Hamlet Biopharma’s EMA approval for the phase III study of neoaduvant therapy for early bladder ...

Jul

17

2026

Uppdatering inför ordinarie teckningsperiod för teckningsoptioner TO5B Ordinarie teckningsperiod för teckningsoptioner av serie TO5B är mellan 20 – 31...

Jul

16

2026

Hamlet BioPharma går nu vidare med förhandlingar om villkor och ramar för slutförande av läkemedelsutveckling och kommersialisering av Alpha1H Tillsam...

Jun

29

2026

Hamlet BioPharma, a pharmaceutical company specializing in the development of novel treatments for cancer and infectious diseases, today announces reg...

Jun

29

2026

Den digitala analysplattformen Briefglance har uppmärksammat Hamlet BioPharma och samarbetet med Universitetet i Iowa kring utvecklingen av Alpha1H fö...

Jun

25

2026

Hamlet BioPharma today announces the successful release of the Phase III quality batch of Alpha1H for use in clinical trials of bladder cancer in Euro...

Jun

23

2026

Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 30th of June 2026, at 12:00. Please click on the link below to partic...

Jun

22

2026

Hamlet BioPharma AB (publ) today announced the signing of a clinical trial agreement with the University of Iowa, one of the leading U.S. centers for ...

Jun

17

2026

Hamlet BioPharma AB (publ) today conducted a pre-initiation visit at the Department of Urology at Charles University, Prague, led by Professor Marek B...

Jun

10

2026

The Journal of Infectious Diseases publishes the paper “Targeting the disease response with NlpD and LytM for effective non-antibiotic treatment of ur...

Jun

08

2026

Hamlet BioPharma AB (publ) meddelar idag att bolaget inlett ett samarbete med University of IOWA, ett amerikanskt center inom uro-onkologi med fokus p...

May

22

2026

  ...

May

21

2026

Hamlet BioPharma invites you to the investors’ meeting to be held on the 22nd of May 2026, at 12:00. Please click on the link below to participate in ...

May

18

2026

Hamlet Biopharma, a company innovating the treatment of cancer and infections, today announced the successful granting of new patents in Japan and Ind...

Apr

23

2026

Hamlet BioPharma invites you to the monthly digital investors’ meeting to be held on the 29th of April 2026, at 12:00. Please click on the link below ...

Mar

30

2026

Hamlet BioPharma AB, an innovative pharmaceutical company developing new therapies for cancer and infections, announces that the company presented its...

Mar

24

2026

Hamlet BioPharma, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar att bolaget tillförs cirka 8.5 miljon...

Mar

17

2026

Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 18th of March 2026, at 12:00. Please click on the link below to parti...

Mar

15

2026

Lund, 15 mars 2026, Hamlet BioPharma, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar att styrelsen har...

Mar

09

2026

Som tidigare meddelats har Hamlet BioPharma, tillsammans med det helägda dotterbolag Alpha1H BC AB (A1HB) och samarbetspartnern Linnane Pharma AB, und...

Mar

08

2026

Hamlet BioPharma AB (Hamlet), a clinical‑stage biopharmaceutical company advancing targeted oncological and other therapies, today announces that its ...

Feb

23

2026

Nature Microbiology publicerar banbrytande studie om icke-antibiotisk behandling av återkommande urinvägsinfektioner Hamlet BioPharma, det innovativa ...

Feb

18

2026

Catharina Svanborg featured in Global Digital Women’s Magazine Read the interview with Hamlet BioPharma’s founder Catharina Svanborg on Femest.com, p...

Feb

13

2026

  ...

Feb

12

2026

This groundbreaking study introduces an entirely new approach to managing recurrent urinary tract infections. Instead of killing the bacteria, the tre...

Feb

11

2026

Hamlet BioPharma invites you to our February investors’ meeting to be held on the 13th of February 2026, at 12:00. Please click on the link below to p...

Feb

03

2026

Hamlet BioPharma has signed an agreement with the Korean biotech company ImmunoForge, to develop novel administration technology for the peptide drug ...

Jan

27

2026

We warmly welcome you to the Symposium on “𝗡𝗼𝘃𝗲𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿.” The invited speakers are leading international scientists with...

Jan

16

2026

Welcome to Hamlet BioPharma’s monthly digital meeting on January 21 at 12:00, held the same day as the Davos Summit discusses ‘’The Fragile Future of ...

Dec

18

2025

The Swedish Cancer Society, Cancerfonden, is a powerful and important research support organization in Sweden. Based mainly on donations, Cancerfonden...

Dec

04

2025

Vid årsstämma i Hamlet BioPharma AB, org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) den 4 december 2025 fattades de beslut som beskrivs neda...

Nov

14

2025

Federal and Drug Administration i USA (FDA) har som tidigare meddelats lämnat skriftlig feedback som stöder Hamlet BioPharmas planerade Fas III‑studie...

Nov

14

2025

    ...

Nov

13

2025

Klicka på länken nedan för att delta. Det går bra att ställa frågor till bolaget genom att e-posta dem till: fraga@investorstudios.se. Sändningen star...

Nov

12

2025

Förslag ny styrelsesammansättning och ny ordförande Inför ordinarie årsstämma i Hamlet BioPharma föreslår större ägare omval av Catharina Svanborg, Ma...

Nov

10

2025

HAMLET BioPharma, a clinical‑stage biopharmaceutical company advancing targeted oncological and other therapies, today announced it has received writt...

Nov

05

2025

One of the most comprehensive studies ever conducted in childhood urinary tract infection shows that a chaotic immune response causes symptoms and dam...

Nov

05

2025

En av de mest omfattande studierna någonsin av urinvägsinfektion hos barn visar att ett kaotisk immunsvar orsakar symptom och vävnadsskada – int...

Dec

07

2023

The brain and spinal cord form the central nervous system, where vital functions are controlled. Brain tumors that disturb those functions may be...